Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy.

Calvillo-Argüelles, Oscar; Abdel-Qadir, Husam; Michalowska, Maria; Billia, Filio; Suntheralingam, Sivisan; Amir, Eitan; Thavendiranathan, Paaladinesh

Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy.

Calvillo-Argüelles, Oscar; Abdel-Qadir, Husam; Michalowska, Maria; Billia, Filio; Suntheralingam, Sivisan; Amir, Eitan; Thavendiranathan, Paaladinesh.

Affiliation

Calvillo-Argüelles O; Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Cancerología (INCan), Unidad de Cardio-Oncología, Mexico City, Mexico.
Abdel-Qadir H; Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
Michalowska M; Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Billia F; Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Suntheralingam S; Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Thavendiranathan P; Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: dinesh.thavendiranathan@uhn.ca.

Can J Cardiol ; 35(2): 153-159, 2019 02.

Article de En | MEDLINE | ID: mdl-30760421

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Récepteur ErbB-2 / Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase / Trastuzumab / Cardiopathies Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Middle aged Langue: En Journal: Can J Cardiol Sujet du journal: CARDIOLOGIA Année: 2019 Type de document: Article Pays d'affiliation: Mexique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google